carrier screening BillionToOne Secures $83.5M in Private Funding, Loan Facility; Shows Clinical Performance of NIPT Premium In a recent study, pregnancy outcomes correlated with the Unity test's fetal risk estimates for recessive conditions, and the company is now conducting further validation studies. Oxford Nanopore Technologies, Bio-Techne Partner to Develop Carrier Screening Assay The project will leverage Asuragen's long-range PCR and Oxford Nanopore's sequencing capabilities to develop a sequencing workflow for carrier screening. Kindbody Acquires Phosphorus, Plans to Adapt Lab for Fertility Testing The genetic testing and consumer genomics company will be renamed KindLabs and will provide reproductive health testing for Kindbody's US clinics. Yourgene Health, Ambry Genetics Team on Genomic Services Under Extended Strategic Partnership The firms are giving each other access to their technologies and assays, which will allow Ambry to include NIPT in its digital screening support product. Sema4 Q3 Revenues Rise 12 Percent For the quarter ended Sept. 30, the firm reported $43.2 million in revenues, up from $38.6 million in Q3 of 2020 and beating the average Wall Street estimate. Oct 21, 2021 UK Biobank Study Investigates Incomplete Penetrance of Mendelian Disease Variants Jul 22, 2021 Sema4 Closes SPAC Deal With CM Life Sciences, Raising Approximately $500M Premium Jul 20, 2021 ACMG Updates Carrier Screening Recommendations for Autosomal Recessive, X-Linked Conditions Jul 1, 2021 BillionToOne Adapting Fetal Dx Tech for Liquid Biopsy, Cancer Therapy Response Monitoring Premium Nov 19, 2020 Putting Expanded Carrier Screening Into Practice Requires Considerations to Avoid Pitfalls Premium Nov 9, 2020 Progenity Q3 Revenues Increase 38 Percent Oct 23, 2020 BTIG Initiates Coverage of Progenity With Buy Rating Aug 3, 2020 Pacific Biosciences, Asuragen Collaborate on Clinical Assays May 31, 2020 Polygenic Risk Score, Family History Refine Breast Cancer Risk Assessment in CHEK2 Mutation Carriers Mar 10, 2020 BillionToOne Closes $15M Series A Follow-on Round Nov 12, 2019 India's IndiGen Project to Sequence 20K Genomes, Support New Clinical Applications Premium Nov 6, 2019 Natera Reports 19 Percent Increase in Q3 Revenues Aug 7, 2019 Natera Q2 Revenues Rise 18 Percent Jul 26, 2019 Invitae Reflects on Consumer-Initiated Test Pilot, Plans Improvements to Counseling Outreach Premium May 8, 2019 BillionToOne to Launch Noninvasive Prenatal Screening Test; Plans Liquid Biopsy Products Premium Feb 20, 2019 Preventive Genomic Screening of Young Adults Could be Cost-Effective, Australian Research Suggests Jan 30, 2019 ArcherDx Acquires Baby Genes Dec 20, 2018 CancerIQ Seeks to Streamline Genetic Risk Screening Premium Dec 19, 2018 Oppenheimer Initiates Coverage of Genomic Health at Perform, Invitae at Outperform Oct 4, 2018 Mayo Clinic Launches Educational Consumer Genetics App That Also Provides Some Health Results Premium Load More Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.